Last year, the San Diego-based Emlyn Group surveyed 250 biotechnology companies in the United States and Canada and received responses from 23 firms. The results of the study were released earlier this year.
Of the companies responding to the survey, 82.6 percent are independently owned firms and 56.5 percent are privately held. About 61 percent specialize in pharmaceuticals, and 26 percent focus on diagnostics. Some 17.4 percent supply equipment or materials, while 4.3 percent are in bioagriculture, including pesticides and vegetables. Software firms constituted 4.3 percent of the respondents. On average, the companies employ 140 people. About half (51.4 percent) of these employees are engaged in research, product development, quality assurance, manufac- turing, or some form of technical support. The other half consists of managers, administrators, and supervisors.
The San Diego-based Emlyn Group's survey of 23 biotechnology companies from the United States and Canada yielded the following findings, among others: ...
